Cancel Preloader

Tag Archives for trials

22December

Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustatin GM2 and NPC patients, is now fully enrolled
Research, Trials

Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustatin GM2 and NPC patients, is now fully enrolled

Read More

07August

Passage Bio announces promising interim clinical data from first right patient with GM1 Gangliosidosis in IMAGINE-1 study
Research, Trials

PHILADELPHIA, Aug. 07, 2023 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic…

Read More

Categories